Syntax Research, Inc.
- SEC CIK
- 0001999827
- Latest filing
- Jul 31, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −100−100.0% | Sold out | Holders |
| Q2 2025 | 100 | $2.76K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 100 | $2.83K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 100 | $4.16K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 100 | $6.68K | <0.1% | +100 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −50−100.0% | Sold out | Holders |
| Q4 2023 | 50 | $4.97K | <0.1% | +50 | New | Holders |